Interferon-alpha2a

DRUG2 trials

Sponsors

University Hospital Tuebingen, Royal Marsden NHS Foundation Trust

Conditions

Behcet's DiseaseMultiple MyelomaPanuveitisPosterior UveitisRetinal Vasculitis

Phase 2

A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma

CompletedNCT00323505

Royal Marsden NHS Foundation TrustMultiple Myeloma

Start: 2001-03-31End: 2004-12-31Updated: 2006-05-09

Phase 3

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

CompletedNCT00167583

University Hospital TuebingenBehcet's Disease, Panuveitis, Posterior Uveitis +1

Start: 2004-11-30End: 2014-12-31Updated: 2018-05-17